RMB, 100% agree. But...that is on Amarin. There is zero education or marketing going on, so it's tough to expect physicians to learn this shit through osmosis. There's over 20,000 drugs on the market in the U.S.
Amarin was marketing in earnest only for a year or so after REDUCE-It, so most physicians that are familiar with Vascepa, have only been educated on the MARINE indication that they were marketing for years prior.
Market Data 
Markets 
AI
